[1] Iyengar P,Kavanagh BD,Wardak Z,et al. Phase Ⅱ trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer[J]. J Clin Oncol,2014,32(34):3824-3830.[2] Xia T,Li H,Sun Q,Wang Y,et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer[J]. Int J Radiat Oncol Biol Phys,2006,66(1):117-125.[3] 申戈,张伟京周振山,等. 肺部小肿瘤γ-刀照射与三维适形及调强放疗计划的剂量学比较[J]. 中华放射肿瘤学杂志,2011,20(1):60-63.[4] 吴昊. 肺部小肿瘤射波刀照射与三维适形及调强放疗计划的剂量学比较[D]. 大连:大连医科大学, 2013.[5] 卢峰,宋钢,毕明卫,等. γ-刀不同聚焦方式形成的辐射野比较[J]. 中华放射医学与防护杂志,2015,35(5):384-388.[6] 徐义果,徐志勇,陈俊超. 陀螺旋转式60Co伽玛刀的性能测试[J]. 中华放射医学与防护杂志,2012,32(3):308-310.[7] Kong FM,Ritter T,Quint DJ,et al. Consideration of dose limits for organs at risk of thoracic radiotherapy:atlas for lung,proximal bronchial tree,esophagus,spinal cord,ribs,and brachial plexus[J].Int J Radiation Oncology Biol Phys,2011,81(5):1442-1457.[8] 吴凤,肖建平,张可,等. IMRT和SRT大分割治疗肺部肿瘤的剂量分布研究[J].中华放射肿瘤学杂志,2009,18(4):281-284.[9] Chavaudra J,Bridier A.Definition of volumes in external radiotherapy:ICRU reports 50 and 62[J].Cancer Radiother,2001,5:472-478.[10] Feuvret L,Noel G,Mazeron JJ,et al.Conformity index:a review[J].Int J Radiat Oncol Biol Phys,2006,64:333-342.[11] Wulf J,Hadinger U,Oppitz U,et al. Stereotactic radiotherapy of targets in the lung and liver[J]. Strahlenther Onkol,2001,177(12):645-655.[12] 段正澄,黄禹. 全身伽玛刀及其适形调强治疗[J].华中科技大学学报:自然科学版,2007,35(2):107-109.[13] 夏廷毅,李宏奇,王颖杰,等. 全身γ刀治疗不能手术Ⅰ和Ⅱ期非小细胞肺癌的临床结果[J]. 中华放射肿瘤学杂志,2007,16(2):91-97.[14] Zhang FL,Zheng MM,Zhang JB,et al. An anthropomorphic phantom study of effect of lung tumour size and location on dosimetric parameters[J]. China-German J Clin Oncol,2010,9(3):133-136. |